找到约 59 条 “IOX2” 相关结果 （用时 0.048 秒）
| 目录号 | 产品名称 | 中文名称 | 靶点 |
|---|---|---|---|
M2573
|
IOX2 | IOX2 | HIF |
| IOX2是一种有效的HIF-1α prolyl hydroxylase-2 (PHD2)（HIF-1α脯氨酰羟化酶-2）抑制剂，IC50为21 nM，比作用于JMJD2A， JMJD2C， JMJD2E， JMJD3和2OG氧合酶FIH选择性高100倍以上。 | |||
| M11603 | ChemBridge-5106399 | ChemBridge化合物-5106399 | Screening Compounds and Building Blocks |
| methyl 4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-2-butynoate (5106399) | |||
| ChemBridge特有类药化合物/先导化合物-5106399，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11615 | ChemBridge-5109057 | ChemBridge化合物-5109057 | Screening Compounds and Building Blocks |
| 2-{[1-(4-bromophenyl)-2,5-dioxo-3-pyrrolidinyl]thio}-N-2-naphthylacetamide (5109057) | |||
| ChemBridge特有类药化合物/先导化合物-5109057，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11621 | ChemBridge-5112759 | ChemBridge化合物-5112759 | Screening Compounds and Building Blocks |
| 1-(2-furylmethylene)-6-methyl-4-thioxo-4,5-dihydrofuro[3,4-c]pyridin-3(1H)-one (5112759) | |||
| ChemBridge特有类药化合物/先导化合物-5112759，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11629 | ChemBridge-5114006 | ChemBridge化合物-5114006 | Screening Compounds and Building Blocks |
| ethyl 3-(benzylamino)-2-(3-chloro-1,4-dioxo-1,4-dihydro-2-naphthalenyl)-3-phenylacrylate (5114006) | |||
| ChemBridge特有类药化合物/先导化合物-5114006，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11634 | ChemBridge-5115805 | ChemBridge化合物-5115805 | Screening Compounds and Building Blocks |
| ethyl 1-(2-hydroxy-1,3-dioxo-2,3-dihydro-1H-inden-2-yl)-2-oxocyclopentanecarboxylate (5115805) | |||
| ChemBridge特有类药化合物/先导化合物-5115805，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11641 | ChemBridge-5118173 | ChemBridge化合物-5118173 | Screening Compounds and Building Blocks |
| 3-(1,4-dioxaspiro[4.5]dec-2-ylmethyl)-2-isopropyl-1,3-oxazolidine (5118173) | |||
| ChemBridge特有类药化合物/先导化合物-5118173，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11668 | ChemBridge-5133193 | ChemBridge化合物-5133193 | Screening Compounds and Building Blocks |
| 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoic acid (5133193) | |||
| ChemBridge特有类药化合物/先导化合物-5133193，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11676 | ChemBridge-5135600 | ChemBridge化合物-5135600 | Screening Compounds and Building Blocks |
| 9,10-dioxo-N-phenyl-9,10-dihydro-2-anthracenesulfonamide (5135600) | |||
| ChemBridge特有类药化合物/先导化合物-5135600，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11691 | ChemBridge-5140203 | ChemBridge化合物-5140203 | Screening Compounds and Building Blocks |
| 4-nitrophenyl (1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetate (5140203) | |||
| ChemBridge特有类药化合物/先导化合物-5140203，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11697 | ChemBridge-5141565 | ChemBridge化合物-5141565 | Screening Compounds and Building Blocks |
| 4-amino-1-[6-(hydroxymethyl)-2-oxidotetrahydrofuro[3,4-d][1,3,2]dioxathiol-4-yl]-2(1H)-pyrimidinone hydrochloride (5141565) | |||
| ChemBridge特有类药化合物/先导化合物-5141565，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11715 | ChemBridge-5146442 | ChemBridge化合物-5146442 | Screening Compounds and Building Blocks |
| 2,2'-{(4,4'-dioxo-2,2'-dithioxo-5,5'-bi-1,3-thiazolidine-3,3'-diyl)bis[(1-oxo-3,1-propanediyl)imino]}dibenzoic acid (5146442) | |||
| ChemBridge特有类药化合物/先导化合物-5146442，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11720 | ChemBridge-5149378 | ChemBridge化合物-5149378 | Screening Compounds and Building Blocks |
| N-(5-chloro-2-pyridinyl)-6-methyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinesulfonamide (5149378) | |||
| ChemBridge特有类药化合物/先导化合物-5149378，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11721 | ChemBridge-5149498 | ChemBridge化合物-5149498 | Screening Compounds and Building Blocks |
| 3-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-(2-hydroxyphenyl)propanamide (5149498) | |||
| ChemBridge特有类药化合物/先导化合物-5149498，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11723 | ChemBridge-5149715 | ChemBridge化合物-5149715 | Screening Compounds and Building Blocks |
| 4-methyl-2-oxo-2H-chromen-7-yl {[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methyl-4-oxo-4H-chromen-7-yl]oxy}acetate (5149715) | |||
| ChemBridge特有类药化合物/先导化合物-5149715，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11745 | ChemBridge-5158496 | ChemBridge化合物-5158496 | Screening Compounds and Building Blocks |
| sodium 4-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)butanoate (5158496) | |||
| ChemBridge特有类药化合物/先导化合物-5158496，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11746 | ChemBridge-5158497 | ChemBridge化合物-5158497 | Screening Compounds and Building Blocks |
| 4-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)-N-hydroxybutanamide (5158497) | |||
| ChemBridge特有类药化合物/先导化合物-5158497，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11749 | ChemBridge-5160780 | ChemBridge化合物-5160780 | Screening Compounds and Building Blocks |
| 2-[5-(4-nitrophenoxy)-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl]benzoic acid (5160780) | |||
| ChemBridge特有类药化合物/先导化合物-5160780，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11752 | ChemBridge-5162044 | ChemBridge化合物-5162044 | Screening Compounds and Building Blocks |
| 5-(2-nitrobenzylidene)-2-thioxo-1,3-thiazolidin-4-one (5162044) | |||
| ChemBridge特有类药化合物/先导化合物-5162044，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11758 | ChemBridge-5171838 | ChemBridge化合物-5171838 | Screening Compounds and Building Blocks |
| 2,6-dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylic acid -2-ethyl-3,9-dimethyl-6,7,8,9-tetrahydro-5H-pyrido[2,3-b]azepin-4-amine (1:1) (5171838) | |||
| ChemBridge特有类药化合物/先导化合物-5171838，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11780 | ChemBridge-5176187 | ChemBridge化合物-5176187 | Screening Compounds and Building Blocks |
| 1,3-dioxo-2-(2-pyrimidinyl)-5-isoindolinecarboxylic acid (5176187) | |||
| ChemBridge特有类药化合物/先导化合物-5176187，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11789 | ChemBridge-5186324 | ChemBridge化合物-5186324 | Screening Compounds and Building Blocks |
| N-(4-bromophenyl)-2-(4-{[(4-bromophenyl)amino]carbonyl}phenyl)-1,3-dioxo-5-isoindolinecarboxamide (5186324) | |||
| ChemBridge特有类药化合物/先导化合物-5186324，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11790 | ChemBridge-5186522 | ChemBridge化合物-5186522 | Screening Compounds and Building Blocks |
| 5,5'-[carbonylbis(1,3-dioxo-1,3-dihydro-2H-isoindole-5,2-diyl)]diisophthalic acid (5186522) | |||
| ChemBridge特有类药化合物/先导化合物-5186522，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11791 | ChemBridge-5186588 | ChemBridge化合物-5186588 | Screening Compounds and Building Blocks |
| 3,5-bis(5-nitro-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzoic acid (5186588) | |||
| ChemBridge特有类药化合物/先导化合物-5186588，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11802 | ChemBridge-5200824 | ChemBridge化合物-5200824 | Screening Compounds and Building Blocks |
| 5-(4-isopropylbenzylidene)-2-thioxo-1,3-thiazolidin-4-one (5200824) | |||
| ChemBridge特有类药化合物/先导化合物-5200824，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11809 | ChemBridge-5210574 | ChemBridge化合物-5210574 | Screening Compounds and Building Blocks |
| 4-(4-{[2-(1-naphthyl)-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl]carbonyl}phenoxy)benzoic acid (5210574) | |||
| ChemBridge特有类药化合物/先导化合物-5210574，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11822 | ChemBridge-5212809 | ChemBridge化合物-5212809 | Screening Compounds and Building Blocks |
| N-[3-(dimethylamino)-1,4-dioxo-1,4-dihydro-2-naphthalenyl]acetamide (5212809) | |||
| ChemBridge特有类药化合物/先导化合物-5212809，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11831 | ChemBridge-5213898 | ChemBridge化合物-5213898 | Screening Compounds and Building Blocks |
| 6,7-dihydro[1,4]dioxino[2,3-f][1,3]benzothiazol-2-amine (5213898) | |||
| ChemBridge特有类药化合物/先导化合物-5213898，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11840 | ChemBridge-5217444 | ChemBridge化合物-5217444 | Screening Compounds and Building Blocks |
| 6-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)-N-hydroxyhexanamide (5217444) | |||
| ChemBridge特有类药化合物/先导化合物-5217444，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11849 | ChemBridge-5221100 | ChemBridge化合物-5221100 | Screening Compounds and Building Blocks |
| N-(3-nitrophenyl)-9,10-dioxo-9,10-dihydro-2-anthracenesulfonamide (5221100) | |||
| ChemBridge特有类药化合物/先导化合物-5221100，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M2134
|
Vortioxetine hydrobromide | 沃替西汀氢溴酸 | 5-HT Receptor |
| Lu AA21004 | |||
| Vortioxetine (Lu AA21004) HBr是一种5-羟色胺抑制剂，抑制5-HT1A， 5-HT1B， 5-HT3A， 5-HT7受体和SERT，IC50分别为15 nM， 33 nM， 3.7 nM， 19 nM和1.6 nM。 | |||
M2568
|
IDO-IN-2 (NLG-919 Analogue) | 那沃莫德；那伏莫德；吲哚胺 2：3-二氧合酶 1 抑制剂；色氨酸 2：3-二氧合酶抑制剂 | IDO |
| GDC-0919 analogue | |||
| NLG919是一种新型有效的indoleamine-2，3-dioxygenase (IDO)（吲哚胺-2，3-双加氧酶）抑制剂，EC50为75 nM。 | |||
| M2862
|
MNS | MNS | Src-bcr-Abl |
| NSC 170724; 5-(2-Nitrovinyl)benzodioxole | |||
| MNS (3,4-Methylenedioxy-β-nitrostyrene, MDBN)是一种酪氨酸激酶抑制剂，抑制Syk， Src和p97， IC50分别为2.5 μM， 29.3 μM和1.7 μM。此外，MNS还能通过抑制NLRP3，从而抑制泛凋亡(PANoptosis)。 | |||
| M6831
|
IOX1 | IOX1 | Histone demethylase |
| IOX-1 | |||
| IOX1是一个2OG oxygenases强效的广谱抑制剂，对KDM4A和KDM3A的IC50值分别为0.6 uM和0.1 uM。IOX1也抑制ALKBH5。 | |||
| M8395 | REDD1 inducer | REDD1 inducer | Others |
| 6-(1,3- dioxo -6-(piperidin |
|||
| M10799 | BMS-986242 | BMS-986242 | IDO |
| BMS-986242 是一种具有口服活性、强效和选择性的 indoleamine-2,3-dioxygenase 1 (IDO1) 抑制剂。BMS-986242 可用于癌症研究。 | |||
| M11006
|
IOX4 | IOX4 | HIF |
| IOX4 是一种选择性 PHD2 抑制剂，IC50 值为 1.6 nM，在细胞和野生型小鼠中诱导 HIFα 表达，可通透血脑屏障。IOX4 与 PHD2 活性位点的 2-氧代戊二酸 (2OG) 竞争并置换。 | |||
| M16895 | 2,3-Di(3',4'-methylenedioxybenzyl) -2-buten-4-olide | 2,3-Di(3',4'-methylenedioxybenzyl) -2-buten-4-olide | Lignans |
| 2,3-Di(3',4'-methylenedioxybenzyl) -2-buten-4-olide | |||
| M16993 | 2-(2,2-Dimethyl-1,3-dioxolan -4-yl)propane-1,2-diol | 2-(2,2-Dimethyl-1,3-dioxolan -4-yl)propane-1,2-diol | Others |
| 2-(2,2-Dimethyl-1,3-dioxolan -4-yl)propane-1,2-diol | |||
| M16994 | 1,6-Dioxaspiro[4.5]decan-2-methanol | 1,6-Dioxaspiro[4.5]decan-2-methanol | Others |
| 1,6-Dioxaspiro[4.5]decan-2-methanol | |||
| M17936 | Kaempferol-3-O-α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranosyl-(1→2)-β-D-glucopyranoside | Kaempferol-3-O-α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranosyl-(1→2)-β-D-glucopyranoside | Others |
| Kaempferol-3-O-α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranosyl-(1→2)-β-D-glucopyranoside 是一种抗氧化剂 (antioxidant)，IC50 为 26.6 μM (DPPH测定)。 | |||
| M17940 | (3β,7β,12β,20Z )-3,7,12-trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid | 3β,7β,12β-三羟基-11,15,23-三羰基-羊毛甾-8,20-二烯-26-酸 | Others |
| (3β,7β,12β,20Z)-3,7,12-Trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid 是一种羊毛脂三萜，在 LPS 诱导的 BV-2 小胶质细胞表现明显的 NO 抑制活性，IC50 为 9.55 uM。 | |||
| M17946 | Lanosta-8,20 (22)-dien-26-oic acid, 15-hydroxy-3,11,23-trioxo-, (15α,20Z)- | Lanosta-8,20 (22)-dien-26-oic acid, 15-hydroxy-3,11,23-trioxo-, (15α,20Z)- | Others |
| 15a-Hydroxy-3,11,23-trioxo-lanost-8,20-dien-26-oic acid 是一种羊毛脂三萜，对脂多糖诱导的小胶质细胞具有抑制 NO 产生的活性。 | |||
| M17947 | Chol-8-en-24-oic acid, 7,15-dihydroxy-4,4,14-trimethyl-3,11-dioxo-, (5α)- | Chol-8-en-24-oic acid, 7,15-dihydroxy-4,4,14-trimethyl-3,11-dioxo-, (5α)- | Others |
| 7,15-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8-en-24-oic acid 是一种灵芝三萜类化合物（灵芝中重要的生物活性成分，可用于研究慢性肝病）。 | |||
| M27893 | Antioxidant agent-10 | Antioxidant agent-10 | Others |
| Antioxidant agent-10 (Compound 3) 是一种具有中等 DPPH 清除活性的抗氧化剂，EC50 为 33.2 μg/mL。 | |||
| M28559 | (R)-FL118 | (R)-FL118 | Others |
| 10,11-(Methylenedioxy)-20(R)-camptothecin | |||
| (R)-FL118 (10,11-(Methylenedioxy)-20(R)-camptothecin) 是 FL118 的 R 型异构体。(R)-FL118 具有抗癌 (anticancer) 活性。 | |||
| M29484 | IDO-IN-13 | IDO-IN-13 | IDO |
| IDO-IN-13 是一种有效的 indoleamine 2,3-dioxygenase 1 (IDO1) 抑制剂，EC50 值为 17 nM，详细信息请参考 WO2019040102A1，example 43。 | |||
| M43876 | 1,1-Dimethylethyl 6-(2,6-dioxo-3-piperidinyl)-3,4-dihydro-2(1H)-isoquinolinecarboxylate | 1,1-Dimethylethyl 6-(2,6-dioxo-3-piperidinyl)-3,4-dihydro-2(1H)-isoquinolinecarboxylate | Ligand for E3 Ligase |
| 1,1-Dimethylethyl 6-(2,6-dioxo-3-piperidinyl)-3,4-dihydro-2(1H)-isoquinolinecarboxylate | |||
| M29809 | NU223612 | NU223612 | PROTAC |
| NU223612 是一种有效的 PROTAC (PROTACs)，可降解吲哚胺 2,3-双加氧酶 1 (IDO1) (Indoleamine 2,3-Dioxygenase (IDO))，Kd 为 640 nM。NU223612 通过 CRBN 介导的蛋白酶体降解有效降解 IDO1 蛋白。NU223612 以 290 nM 的亲和力与 CRBN 结合。NU223612 可以穿过血脑屏障 (BBB)。 | |||
| M30730 | 5,8-Epidioxyergosta-6,9(11),22-trien-3-ol | 5,8-Epidioxyergosta-6,9(11),22-trien-3-ol | Apoptosis |
| 9,11-Dehydroergosterol peroxide; 9(11)-DHEP | |||
| 5,8-Epidioxyergosta-6,9(11),22-trien-3-ol (9,11-Dehydroergosterol peroxide)，一种来自药用蘑菇的重要甾体，对几种肿瘤类型具有抗肿瘤活性。5,8-Epidioxyergosta-6,9(11),22-trien-3-ol 通过诱导 CDKN1A 表达抑制 HT29 细胞生长，从而导致细胞周期停滞和凋亡。 | |||
| M31050 | Rivanicline hemioxalate | Rivanicline hemioxalate | AChR/AChE |
| RJR-2403 hemioxalate; (E)-Metanicotine hemioxalate | |||
| Rivanicline hemioxalate (RJR-2403 hemioxalate; (E)-Metanicotine hemioxalate) 是神经元烟碱受体 (neuronal nicotinic receptor) 激动剂，对 α4β2 亚型有高度选择性，Ki 为 26 nM，而对 α7 受体的 Ki 则为3.6 μM。 | |||
| M38771 | 1,4-Epidioxybisabola-2,10-dien-9-one | 1,4-Epidioxybisabola-2,10-dien-9-one | Anti-infection |
| 1,4-Epidioxybisabola-2,10-dien-9-one 是 1,4-epidioxy-bisabola-2,12-diene 的衍生物，可从 Curcuma longa L. 中分离出来。1,4-Epidioxybisabola-2,10-dien-9-one 在 MDCK 细胞系中表现出抗流感病毒 A/PR/8/34 (H1N1) 的抗病毒活性，IC50 为 16.79 ± 4.03 μg/mL。 | |||
| M41161 | Helioxanthin | Helioxanthin | Anti-infection |
| Helioxanthin (ACH126447) 具有体外抗病毒活性，对HBV的EC50为1 μM，还可抗黄病毒。 | |||
| M41897 | RTIOXA-43 | RTIOXA-43 | OX Receptor |
| RTIOXA-43 是一种食欲素受体 (orexin receptor) 激动剂，对于 OX2 和 OX1 受体的 EC50 值均为 24 nM。 | |||
| M43850 | 2-[5-(2,6-Dioxo-3-piperidinyl)-2-pyridinyl]-2-azaspiro[3.3]heptane-6-acetic acid | 2-[5-(2,6-Dioxo-3-piperidinyl)-2-pyridinyl]-2-azaspiro[3.3]heptane-6-acetic acid | Ligand for E3 Ligase |
| 2-[5-(2,6-Dioxo-3-piperidinyl)-2-pyridinyl]-2-azaspiro[3.3]heptane-6-acetic acid | |||
| M43851 | 1-[5-(2,6-Dioxo-3-piperidinyl)-2-pyridinyl]-4-piperidineacetic acid | 1-[5-(2,6-Dioxo-3-piperidinyl)-2-pyridinyl]-4-piperidineacetic acid | Ligand for E3 Ligase |
| 1-[5-(2,6-Dioxo-3-piperidinyl)-2-pyridinyl]-4-piperidineacetic acid | |||
| M43860 | 1-[5-(2,6-Dioxo-3-piperidinyl)-3-fluoro-2-pyridinyl]-4-piperidineacetic acid | 1-[5-(2,6-Dioxo-3-piperidinyl)-3-fluoro-2-pyridinyl]-4-piperidineacetic acid | Ligand for E3 Ligase |
| 1-[5-(2,6-Dioxo-3-piperidinyl)-3-fluoro-2-pyridinyl]-4-piperidineacetic acid | |||
| M43861 | 4-Piperidinecarboxylic acid, 1-[5-(2,6-dioxo-3-piperidinyl)-2-pyridinyl]-, 1,1-dimethylethyl ester | 4-Piperidinecarboxylic acid, 1-[5-(2,6-dioxo-3-piperidinyl)-2-pyridinyl]-, 1,1-dimethylethyl ester | Ligand for E3 Ligase |
| 4-Piperidinecarboxylic acid, 1-[5-(2,6-dioxo-3-piperidinyl)-2-pyridinyl]-, 1,1-dimethylethyl ester | |||
| M43862 | 4-Piperidinecarboxaldehyde, 1-[5-(2,6-dioxo-3-piperidinyl)-2-pyridinyl]- | 4-Piperidinecarboxaldehyde, 1-[5-(2,6-dioxo-3-piperidinyl)-2-pyridinyl]- | Ligand for E3 Ligase |
| 4-Piperidinecarboxaldehyde, 1-[5-(2,6-dioxo-3-piperidinyl)-2-pyridinyl]- | |||
